Record US Debt to Drive Bitcoin Price Higher, Says Strike CEOby John Darbie 31.03.2024The US government's debt dilemma explained: defaulting is not an option, making paying it back the only alternative. More dollars ...
Hormel Emerges as Top Dividend Stockby Mark Eisenberg 31.03.2024Coca-Cola, Pepsi, and Hormel all have similar payout ratios, making Hormel the best option for investors. Hormel aims to dominate ...
Influencer Sparks Controversy in the Crypto Communityby John Darbie 31.03.2024Eric Wall provides an explanation of Bittensor's AI system in a Twitter post. He discusses the use of different subnets ...
Microsoft and OpenAI Building $100B Secret Supercomputerby Lilu Anderson 31.03.2024OpenAI's $100 billion commitment to AI raises questions on how the industry will sustain itself. The article delves into the ...
Seabridge Gold (NYSE:SA): Buy, Hold, or Sell?by Mark Eisenberg 30.03.2024SA shares are up 25% YTD, raising $42.8M in 2023. With room for $67.6M in ATM offering, is it a ...
Unlock Hyper-Personalization: Closing the Gapby Lilu Anderson 29.03.2024Closing the gap with big U.S. companies like Amazon and Netflix requires the right data architecture and lightning-fast app performance ...
Reddit Shares Plunge 25%, Finish Week Below Opening Priceby Mark Eisenberg 29.03.2024Shares of Reddit closed below their first-day trading price, ending the week at $49.32. They started strong, soaring 30% on ...
Fairfax County Expands Court Access with Remote Kiosksby Lilu Anderson 29.03.2024The AI program in the county won't generate its own answers. They are also reaching out to nonprofits for kiosk ...
Moleculin Biotech Stock Coverage and Analysis at StockNewsby Mark Eisenberg 28.03.2024Moleculin Biotech's stock has been given a "sell" rating by a firm, with a 1-year low of $4.34 and a ...
Moleculin Biotech Stock Receives “Sell” Rating – Analystsby Mark Eisenberg 28.03.2024Atticus Wealth Management LLC buys stake in Moleculin Biotech as the firm sets a “sell” rating on the stock; MBRX ...